with,VES,3,Shutter,frankboehm.com,Intake,Fan,9,Foot,$132,Cord,Exhaust,Speed,Tools Home Improvement , Building Supplies , HVAC,/,/furlable765477.html,f,Fan, $132 VES Exhaust / Intake Fan, 3 Speed Shutter Fan with 9 Foot Cord f Tools Home Improvement Building Supplies HVAC VES Exhaust Intake Fan 3 Speed Genuine Free Shipping Shutter 9 f with Foot Cord with,VES,3,Shutter,frankboehm.com,Intake,Fan,9,Foot,$132,Cord,Exhaust,Speed,Tools Home Improvement , Building Supplies , HVAC,/,/furlable765477.html,f,Fan, $132 VES Exhaust / Intake Fan, 3 Speed Shutter Fan with 9 Foot Cord f Tools Home Improvement Building Supplies HVAC VES Exhaust Intake Fan 3 Speed Genuine Free Shipping Shutter 9 f with Foot Cord

VES Exhaust Intake Fan 3 Speed Genuine Free Shipping Shutter 9 f with Ranking TOP8 Foot Cord

VES Exhaust / Intake Fan, 3 Speed Shutter Fan with 9 Foot Cord f

$132

VES Exhaust / Intake Fan, 3 Speed Shutter Fan with 9 Foot Cord f

|||

Product Description

VES 3 Speed 12" Exhaust Shutter Fan

PRODUCT FEATURES

  • Totally assembled
  • No electrician is required when the fan is plugged into an approved electrical outlet
  • Safety powder-coated guard on intake side meets OSHA standards
  • 3 wing aluminum balanced blade
  • Motor is sealed, switch and wiring connections have moisture resistant rubber gasket

MOTOR FEATURES

  • Motor is CSA/CSA-US approved
  • Direct Drive
  • 50/60 Hz
  • Horsepower: 1/10
  • 3 speed
  • RPM (High/Medium/Low): 1672/1585/1470
  • Voltage: 115
  • Rotors have been balanced to reduce noise vibration and prolong life
  • Motor enclosures have been machined to lt;0.5mm to reduce rotor shaft play
  • Copper winding
  • Bearing specifications -40˚C to 140˚C
  • Capacitor rating 450vac, 10,000 hours for extended life
  • Silicon steel rotors

VES Exhaust / Intake Fan, 3 Speed Shutter Fan with 9 Foot Cord f

CURRENT ISSUE
September, 2021

No. 106 (9)

2020 Impact Factor: 9.941 Submission > Acceptance: 52 days
ARTICLES IN THREE SENTENCES
Article

Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

This open-label, single-arm study investigated the long-term efficacy of tafasitamab plus lenalidomide in 81 patients with relapsed/refractory diffuse large B-cell lymphoma. The response rate was 57.5%, including complete responses in 40.0% of patients, and the median duration of response was 43.9 months. This treatment is a valuable option for patients not eligible for autologous stem-cell transplantation.

Johannes Duell et al.

Case Report

Clinical genomic profiling of novel grey zone lymphoma paired lesions with sequential central nervous system involvement in two adolescent patients

Grey zone lymphoma is a B-cell lymphoma, unclassifiable, with features intermediate between those of large B-cell lymphoma and classic Hodgkin lymphoma. The in-depth study of the two adolescent patients described in this case report expands the clinicopathological and genomic spectrum of this rare pediatric disease. Moreover, it provides information on their response to treatment.

Cagla Y. Benkli et al.

Article

CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients

The clinical picture of 56 patients with congenital amegakaryocytic thrombocytopenia due to MPL mutations was much more varied than previously thought. Twenty-five per cent of them had no signs of thrombocytopenia at birth, and 50% had non-hematologic defects. Pancytopenia developed in (nearly) all patients and hematopoietic stem-cell transplantation was effective in 87% of cases.

Manuela Germeshausen et al.

Article

Oxidative stress activates red cell adhesion to laminin in sickle cell disease

Sickle red blood cells exhibit abnormal adhesion to laminin mediated by Lu/BCAM protein at their surface. This study provides evidence of the involvement of oxidative stress in post-translational modifications of Lu/BCAM which impact the protein’s distribution and cis-interaction with glycophorin C at the cell surface activating its adhesive function in dense sickle red cells. The authors speculate that antioxidant drugs might attenuate this phenomenon.

Maria Alejandra Lizarralde-Iragorri et al.

TAKE ADVANTAGE FROM HAEMATOLOGICA